The present invention relates to methods of treating viral or fungal infections
using 3-aminopyridine-2-carboxyaldehyde thiosemicarbazone (3-AP) and 3-amino-4-methylpyridine-2-carboxaldehyde
thiosemicarbazone (3-AMP) and its prodrug forms and to pharmaceutical compositions
comprising these compounds.
